Beamtree Signs A$10.1m RippleDown contract with Ampath
- Beamtree (BMT) signs a US$7 million (A$10.1 million) five-year contract with Ampath for its RippleDown software
- RippleDown is Beam tree’s proprietary software that automates the clinical and administrative process by reducing the time pathologists spend reading results
- This partnership follows a successful proof-of-concept pilot trial that examined how RippleDown can help Ampath laboratories drive better healthcare services
- While the contract is for a five-year term, there is an option for termination after two years by giving three months notice
- The company is up 17.7 per cent with shares trading at 30 cents
